November 2020 - Page 3 of 6 - BioMedWire (BMW)

TuesdayNov 17, 2020 11:00 am

Logistical Concerns Arise Over Extremely Low Temperatures Needed for COVID-19 Vaccine Storage

A few days ago, Pfizer announced that it had developed a coronavirus vaccine that had proven to be 90% effective in combating the virus in trials. However, to maintain the vaccine’s efficacy, the vaccine needs to be stored and transported at temperatures below -70º Celsius. An infectious disease and vaccine specialist, Professor Gordon Dougan, from the University of Cambridge, explains that most vaccines are usually stored around or at 4° Celsius. This, he says, is an easy temperature requirement for refrigerated transport. However, the temperature requirements for the coronavirus vaccine, which are extreme, suggest that refrigeration methods that have been…

MondayNov 16, 2020 1:00 pm

Physical Fitness in Children is More Important Than BMI

A new study by the University of Georgia has shown that while grown-ups exercise mostly to lose weight, children should exercise to build endurance, or how well their bodies can handle long periods of exercise. Physical education for children should be centered on motivating children to be active, educating them on the benefits of exercise and improving their physical skills. According to the authors of the study, strengthening children’s cardiorespiratory endurance should be the main goal in exercise for children. Even children who are overweight can still achieve the recommended one hour of moderate to vigorous physical activity every day.…

MondayNov 16, 2020 12:27 pm

Predictive Oncology (NASDAQ: POAI) CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media

CEO expects results that will “build the stock and raise the stock price” POAI focused on positioning TumorGenesis kits to manufacturers Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones and outlined strategic goals. In addition, Schwartz provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics. “I’m very encouraged. I think we’re moving right along. Things never go as fast as we would like them, and it can be…

MondayNov 16, 2020 11:00 am

Gene Marker Suggests Likelihood of Prostate Cancer Metastasizing

Researchers have found a genetic signature that can forecast whether cancer is likely to metastasize or spread in the early stages of localized prostate cancer. The signature can also predict whether the disease will respond to anti-androgen therapy. In addition, the new signature may be beneficial in helping evaluate the disease’s response to treatment as well as creating new treatments to treat or avert the advanced stages of prostate cancer. This groundbreaking study was reported in “Nature Cancer.” A professor of cell biology and pathology in Columbia University’s Irving Medical Center, Cory-Abate-Shen, senior author of the study, states that if…

FridayNov 13, 2020 1:00 pm

Social Distancing Spikes Loneliness Among Older People

According to a new study by researchers from the University of Stirling, the social distancing measures introduced to help contain the coronavirus infection has affected the well-being of Scotland’s older population, increasing their feelings of loneliness. The study discovered a connection between the worsening health and well-being of individuals over 60 years and the growth in loneliness. The research determined that increased loneliness was linked to a decrease in well-being, lower social support and a small social network. The research was launched earlier in May under the Scottish government’s rapid research in coronavirus program. A professor of the University’s Faculty…

FridayNov 13, 2020 10:00 am

Biodegradable Implantable Sensors Can Monitor Body Functions

Using biodegradable materials, an international team of scientists has designed a flexible gas sensor that is highly sensitive and can be implanted in the human body. The sensor, which monitors a patient’s condition during and after medical procedures, biodegrades safely after its use has been exhausted and is absorbed by the body. This is a much better sensor than the sensors currently in use. The current sensors are not only expensive, but they can also be dangerous and uncomfortable. Researchers designed this implantable sensor that can monitor different forms of nitrogen dioxide and nitric oxide gas in the body. These…

ThursdayNov 12, 2020 1:59 pm

VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO Discusses ‘Game-Changing’ Potential of Drug Pipeline Lineup in Stock2Me Podcast

VTGN is committed to developing and commercializing differentiated new generation medications that go beyond the current standard of care for anxiety, depression and other CNS disorders. VTGN currently has three drugs in its pipeline, PH94B and PH10, both innovative synthetic neuroactive steroid nasal sprays, and AV-101, a novel, oral prodrug that targets the NMDAR. VTGN has opportunity, based on current drug-development programs, to “shift the paradigm.” VistaGen Therapeutics (NASDAQ: VTGN) CEO Shawn Singh spoke about VistaGen’s game-changing potential for the treatment of mental illness during a recent episode of InvestorBrandNetwork’s Stock2Me Podcast (https://ibn.fm/34My5). A clinical-stage biopharmaceutical company, VTGN has three drugs…

ThursdayNov 12, 2020 1:00 pm

Researchers Uncover Two Factors That Turn Cells Cancerous

In a novel study that was published in “Cell Metabolism,” researchers have discovered two pathways that may connect more than 100 types of cancer. For a long time, scientists believed that all cancers were controlled by the same set of basic processes. The researchers, who are from the University of Pennsylvania Perelman School of Medicine, may have identified a combined process that could be used to develop new therapies that would prevent cells from mutating into any type of tumor, whether it is colon, prostate or breast tumor. The team of researchers discovered that the enhancement of two elements (nucleotide…

ThursdayNov 12, 2020 10:00 am

Research Discovers That Suicide Rates Spike After Disasters Occur

A group of researchers from the University of Delaware have examined how suicide rates are influenced by various natural disasters. Natural disasters may include tornadoes, floods and hurricanes. and as climate change becomes more harmful, we are seeing these disasters occurring more frequently, each more serious than the last. In fact, the group measured 281 disasters over a 12-year period. Factoring in the effect natural disasters have on local communities, their economies and their infrastructure, it might be plausible to argue that disasters can also cause severe anxiety and emotional distress. The founding director of the University of Delaware’s College…

WednesdayNov 11, 2020 2:12 pm

Predictive Oncology (NASDAQ: POAI) CEO Joins NNW Podcast to Discuss Company’s Prospects; Provides Update on POAI Subsidiaries

Predictive Oncology CEO Carl Schwartz featured on NNW’s podcast to discuss the company’s prospects Schwartz elaborated on company’s various divisions, affirming that POAI had begun to see revenue trends stabilize, cash burn rates decline TumorGenesis received overwhelmingly positive feedback on its initial product launches, with plans to extend its technological prowess to address other oncological segments Soluble Biotech, which announced its first major contract in August, is expected to reveal news of second order win in near future Schwartz touched upon POAI’s Helomics business, stating his belief that division could soon transition towards monetizing its unique and one-of-a-kind asset portfolio…